Rapid in vitro screening. High signal, decision ready.

Cost effective in vitro and organoid screening to de-risk development

We provide fast, reliable in vitro screening to identify the most promising radiopharmaceutical candidates.

Our assays utilise hot samples to deliver clean, quantitative data that de-risks early decisions and accelerates progression.

Why work with us?

In-house specialisms: Deep radiopharmaceutical biology expertise.
Translational depth: Integrated in vitro → in vivo pathway development.
Regulatory‑ready: ISO 45001 certified, in vitro and organoids specialisms, licensed for alpha & beta emitters and predictive human dosimetry from pre-clinical data.
Trusted for reliability: Predictive models and mechanistic insight.
Global credibility: Our environment is built for regulatory credibility – whether your next step is the FDA, EMA or MHRA.

If you need early data that cuts through noise and accelerates decisions, you need us.

Radiopharmaceuticals - A scientist works at a thermal castle in a radiochemistry laboratory for preclinical workstreams to de-risk radiopharmaceutical investment

World-class minds for RPT discovery and development

In the complex landscape of radiochemistry and translational imaging, the difference lies in the expertise behind the science.

Our team comprises industry-leading specialists across preclinical services and radiopharmaceuticals, dedicated to bridging the gap between early discovery and clinical success.

Meet the experts who turn sophisticated data into actionable therapeutic insights.

Explore our scientific expertise

Case study: Target engagement screening

Brief: Rapidly screen multiple constructs for target engagement.

We delivered:

Binding and internalisation data.
Mechanistic insight.
Clear ranking of candidates.

Outcome: One lead selected and progressed to in vivo.

Start your project

Ready to accelerate your in vitro RPT screening project?

Our experts are here to support your journey from concept to clinic. Contact our team to discuss a tailored solution.

Speak to the team, we’ll scope your project and get you moving fast.

Expertise in radiolabelling

With gamma, beta and alpha-emitting radiometals of small molecules (e.g., FAPI, PSMA), peptides, proteins and other biologics containing chelators such as DOTA, DOTAM, Macropa, and DFO/DFO*. Experience in a variety of purification methods (e.g., ultrafiltration, SPE), QC analysis (HPLC, ITLC, gamma spectrometry), and conjugation techniques.

Discover more